NCT05796479View on ClinicalTrials.gov

A PK Comparability Study of Two Different Amlitelimab Drug Products in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 28, 2022

Primary Completion Date

May 22, 2023

Study Completion Date

May 22, 2023

Conditions
Healthy Volunteers
Interventions
DRUG

Amlitelimab DP1

"Injection solution 1~Subcutaneous"

DRUG

Amlitelimab DP2

"Injection solution 2~Subcutaneous"

Trial Locations (1)

33014

Clinical Pharmacology of Miami-Site Number: 8400001, Hialeah

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT05796479 - A PK Comparability Study of Two Different Amlitelimab Drug Products in Healthy Participants | Biotech Hunter | Biotech Hunter